IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,529,155 | +29.6% | 336,078 | +100.6% | 0.00% | +100.0% |
| Q2 2023 | $1,179,594 | +65.5% | 167,556 | +43.6% | 0.00% | 0.0% |
| Q1 2023 | $712,768 | -2.7% | 116,656 | +1.7% | 0.00% | 0.0% |
| Q4 2022 | $732,652 | -47.9% | 114,656 | -22.3% | 0.00% | -50.0% |
| Q3 2022 | $1,406,000 | -5.8% | 147,556 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $1,493,000 | -44.3% | 135,256 | -16.0% | 0.00% | 0.0% |
| Q1 2022 | $2,680,000 | +1.2% | 160,968 | +16.0% | 0.00% | 0.0% |
| Q4 2021 | $2,648,000 | -18.3% | 138,724 | +5.5% | 0.00% | -33.3% |
| Q3 2021 | $3,241,000 | +10.7% | 131,444 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,927,000 | -41.9% | 131,444 | -17.5% | 0.00% | -50.0% |
| Q1 2021 | $5,042,000 | -44.6% | 159,264 | -18.8% | 0.01% | -45.5% |
| Q4 2020 | $9,101,000 | +60.4% | 196,142 | +13.8% | 0.01% | +37.5% |
| Q3 2020 | $5,673,000 | +19.9% | 172,315 | 0.0% | 0.01% | +14.3% |
| Q2 2020 | $4,730,000 | +0.8% | 172,315 | +9.9% | 0.01% | -12.5% |
| Q1 2020 | $4,694,000 | +1.2% | 156,808 | -6.4% | 0.01% | +14.3% |
| Q4 2019 | $4,639,000 | +48.4% | 167,608 | -2.4% | 0.01% | +40.0% |
| Q3 2019 | $3,127,000 | -22.8% | 171,808 | +3.9% | 0.01% | -16.7% |
| Q2 2019 | $4,053,000 | +289.3% | 165,308 | +51.0% | 0.01% | +200.0% |
| Q1 2019 | $1,041,000 | +6.9% | 109,508 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $974,000 | -15.5% | 110,008 | +7.4% | 0.00% | 0.0% |
| Q3 2018 | $1,152,000 | -8.9% | 102,400 | +3.6% | 0.00% | 0.0% |
| Q2 2018 | $1,265,000 | -2.0% | 98,800 | +29.3% | 0.00% | 0.0% |
| Q1 2018 | $1,291,000 | – | 76,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |